⌘K

Home/Filings/4/0001213900-23-017217

4//SEC Filing

Bassan Merav 4

Accession 0001213900-23-017217

CIK 0001739174other

View on SEC.gov Company Profile

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:03 PM ET

Size

5.4 KB

Accession

0001213900-23-017217

Insider Transaction Report

Form 4

Period: 2023-03-01

Chief Development Officer

Transactions

Award
Common Stock Options - Right to Buy
2023-03-01+100,000→ 100,000 total
Exercise: $0.40Exp: 2033-03-01→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 1, 2024, and the remainder vesting in 12 equal quarterly installments over three years.

Documents

1 file

4
ownership.xmlPrimary

Issuer

BiomX Inc.

CIK 0001739174

Entity typeother

Related Parties

1

filerCIK 0001792702

Filing Metadata

Form type: 4
Filed: Mar 2, 7:00 PM ET
Accepted: Mar 3, 4:03 PM ET
Size: 5.4 KB

View on SEC.gov